Raymond James Downgrades PTC Therapeutics (PTCT) to Underperform, 'expect the drug to be officially pulled from the EU market by January 2024'
Tweet Send to a Friend
(Updated - September 15, 2023 9:18 AM EDT)
Raymond James analyst Danielle Brill downgraded PTC Therapeutics (NASDAQ: PTCT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Raymond James analyst Danielle Brill downgraded PTC Therapeutics (NASDAQ: PTCT) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
